Your browser doesn't support javascript.
loading
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.
Robertson, Susan J; Orme, Lisa; Teixeira, Rodrigo; Shamassi, Maryam; Newell, Felicity; Patch, Ann-Marie; Yeh, Iwei; Gard, Grace; Wilmott, James; Jackett, Louise; LeBoit, Philip; Fellowes, Andrew; MacArthur, Grant; Fox, Stephen; Hayward, Nicholas K; Bastian, Boris; Scolyer, Richard; Waddell, Nicola; Penington, Anthony; Shackleton, Mark.
Afiliação
  • Robertson SJ; Department of Dermatology, The Royal Children's Hospital, The Royal Melbourne Hospital and Monash Medical Centre, Melbourne, Australia.
  • Orme L; Murdoch Children's Research Institute, Melbourne, Australia.
  • Teixeira R; Department of Oncology, The Royal Children's Hospital, Melbourne, Australia.
  • Shamassi M; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Newell F; Department of Plastic Surgery, The Royal Children's Hospital, Melbourne, Australia.
  • Patch AM; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
  • Yeh I; Department of Anatomical Pathology, The Royal Children's Hospital, Melbourne, Australia.
  • Gard G; Department of Genetics and Computational Biology, QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute, Brisbane, Australia.
  • Wilmott J; Department of Genetics and Computational Biology, QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute, Brisbane, Australia.
  • Jackett L; Helen Diller Family Comprehensive Cancer Center, Departments of Dermatology and Pathology, University of California, San Francisco.
  • LeBoit P; Department of Medical Oncology, Alfred Health, Melbourne, Australia.
  • Fellowes A; Melanoma Institute Australia, University of Sydney, Sydney, Australia.
  • MacArthur G; Melanoma Institute Australia, University of Sydney, Sydney, Australia.
  • Fox S; Sydney Medical School, University of Sydney, Sydney, Australia.
  • Hayward NK; Royal Prince Alfred Hospital, Camperdown, Australia.
  • Bastian B; Helen Diller Family Comprehensive Cancer Center, Departments of Dermatology and Pathology, University of California, San Francisco.
  • Scolyer R; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Waddell N; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Penington A; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Shackleton M; Department of Genetics and Computational Biology, QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute, Brisbane, Australia.
JAMA Dermatol ; 157(7): 836-841, 2021 Jul 01.
Article em En | MEDLINE | ID: mdl-34076666
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Nevo de Células Epitelioides e Fusiformes / Crizotinibe Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child, preschool / Female / Humans Idioma: En Revista: JAMA Dermatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Nevo de Células Epitelioides e Fusiformes / Crizotinibe Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child, preschool / Female / Humans Idioma: En Revista: JAMA Dermatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália